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Air–liquid interfacestem constitutes an excellent example of howdynamicmembrane polymorphism
governs some biological functions through speciﬁc lipid–lipid, lipid–protein and protein–protein interactions
assembled in highly differentiated cells. Lipid–protein surfactant complexes are assembled in alveolar
pneumocytes in the form of tightly packed membranes, which are stored in specialized organelles called
lamellar bodies (LB). Upon secretion of LBs, surfactant develops amembrane-basednetwork that covers rapidly
and efﬁciently the whole respiratory surface. This membrane-based surface layer is organized in a way that
permits efﬁcient gas exchange while optimizing the encounter of many different molecules and cells at the
epithelial surface, in a cross-talk essential to keep thewhole organism safe frompotential pathogenic invaders.
The present review summarizes what is known about the structure of the different forms of surfactant, with
special emphasis on current models of the molecular organization of surfactant membrane components. The
architecture and the behaviour shown by surfactant structures in vivo are interpreted, to some extent, from the
interactions and the properties exhibited by different surfactant models as they have been studied in vitro,
particularly addressing the possible role played by surfactant proteins. However, the limitations in structural
complexity and biophysical performance of surfactant preparations reconstituted in vitrowill be highlighted in
particular, to allow for a proper evaluation of the signiﬁcance of the experimental model systems used so far to
study structure–function relationships in surfactant, and to deﬁne future challenges in the design and
production of more efﬁcient clinical surfactants.
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The lungs establish the largest surface contact that most air-
breathing vertebrates have with their environment. Exposure of a
sufﬁciently large surface to the air is required to facilitate appropriated
1677J. Pérez-Gil / Biochimica et Biophysica Acta 1778 (2008) 1676–1695levels of gas exchange to support metabolic functions [1,2]. A complex
macromolecular system has evolved in the pulmonated organisms as
part of their environmental interface, to provide optimal properties in
terms of structural stability and accessibility to the air phase while
raising an efﬁcient barrier against environmental insults, including
the entrance of pathogens. Pulmonary surfactant, a membrane-based
lipid–protein complex, which is assembled and secreted onto the
respiratory surface by specialized cells of the alveolar epithelium,
contains molecular components simultaneously responsible for
biophysical stabilizing activities [3] and innate defence mechanisms
[4,5]. Which of these activities evolved ﬁrst is a matter of debate, but it
is becoming clear that the two functions, biophysics and defence, are
now inseparably coordinated in the surfactant system.
Lack of an operative surfactant system is associated with severe
respiratory dysfunctions [6–8]. The pulmonary surfactant system
matures during the last few weeks of gestation, and babies delivered
prematurely before a threshold amount of surfactant has been pro-
duced are at risk of developing Infant Respiratory Distress Syndrome
(IRDS), a major cause of mortality and morbidity in neonates, par-
ticularly before supplementation with exogenous surfactant prepara-
tions was established as a routine therapeutical practice [9,10]. On the
other hand, patients suffering from acute lung injury (ALI), arising
from a number of different potential causes, often develop Acute
Respiratory Distress Syndrome (ARDS) ending in severe respiratory
failure due, at least in part, to inactivation of the surfactant system by
inﬂammatory by-products and blood components leaked into the
airways through a deteriorated alveolar-capillary barrier [11–13].
Much research in this ﬁeld, carried out in the last decades, has been
devoted to elucidating the role of the different lipid and protein
components of surfactant, with the primary purpose of understanding
the molecular mechanisms associated with surfactant function. An
additional objective has been deﬁning the minimal compositional
requirements for an effective therapeutic surfactant [14–17]. Exten-
sive knowledge is available today about structural and physico-
chemical properties of most surfactant components in simpliﬁed
model systems, although we still do not fully understand how the
whole surfactant complex is assembled and developed in vivo or the
molecular mechanisms by which surfactant proteins and membranes
modulate respiratory physiology. The clinical surfactant preparations
available today are effective in preventing and treating IRDS in
preterm babies, but have not proven effective in reverting or
ameliorating ARDS, suggesting that clinical formulations are still
suboptimal, but also that we need to get further insight into the
molecular events deﬁning surfactant action in the complex context of
the alveolar spaces, both in normal and injured lungs.
Apart from the clinical importance of understanding structure–
function correlations in surfactant, the pulmonary surfactant system
constitutes an excellent example of how dynamic membrane poly-
morphism governs some biological functions through speciﬁc lipid–
lipid and lipid–protein interactions assembled in highly differentiated
cells [18–20]. Lipid–protein surfactant complexes are assembled in
pneumocytes in the form of tightly packed membranes, which are
stored in specialized organelles called lamellar bodies (LB). Upon
secretion of LBs, surfactant develops a membrane-based network that
covers rapidly and efﬁciently the whole respiratory surface. This
membrane-based surface phase is organized in such a way that it
permits an efﬁcient exchange of molecules between the gas and the
liquid regions in alveoli, enabling gases to reach the blood stream
ﬂowing on the other side of the thin alveolar-capillary barrier. At the
same time, the respiratory surfactant layer optimizes the encounter
betweenmany differentmolecules and cells at the epithelial surface, in
a cross-talk essential to keep the whole organism safe from potential
pathogenic invaders [5].
The present review summarizes what is known about the structure
of the different forms of surfactant, with special emphasis on current
model systems on themolecular organization of surfactant membranecomponents. The architecture and behaviour shown by surfactant
structures in vivo will be interpreted to some extent from the inter-
actions and properties exhibited by different surfactant models as
they have been studied in vitro, particularly addressing the possible
roles played by surfactant proteins. However, the limitations in struc-
tural complexity and biophysical performance of surfactant prepara-
tions reconstituted in vitro will be particularly highlighted, to allow a
proper evaluation of the signiﬁcance of the experimental models used
so far to study structure–function relationships in surfactant, and to
deﬁne future challenges in the design and production ofmore efﬁcient
clinical surfactants.
2. Pulmonary surfactant: the molecules and the basic interactions
The composition of pulmonary surfactant has been discussed in
detail in other reviews, including its analysis as a reference either to
interpret differences in performance of current clinical surfactant
preparations of natural origin [14] or to rationalize the selection of
protein and lipid components used to produce new artiﬁcial sur-
factants [15,21]. The present review will then sketch only the main
structural features, the potential interactions and some of the self-
organization properties of what are considered the key compositional
elements in surfactant [22,23] (see cartoon in Fig. 1). It is important to
consider that composition of native pulmonary surfactant is usually
studied usingmaterial obtained frombronchoalveolar lavage of animal
lungs. This lavage may collect structures that could coexist in the
airspaces but were assembled separately and/or play different
functions, or from different locations of the respiratory tract. The
traditional approach has been to fractionate the lipid/protein material
obtained from lavage into what has been called large aggregates (LA),
large membrane-based structures with relatively high density and
very good surface activity, and small aggregates (SA), of lighter density
and much less surface active [24–26]. These two fractions are
considered as two different stages of surfactant in its morphological
transformation in the respiratory cycle. However, the possibility that
both LA and the SA fractions are intrinsically heterogeneous and could
contain more than one type of structure, cannot be discarded.
2.1. The lipids and the membrane phases
In general terms, pulmonary surfactant is composed of around 80%
phospholipids, 5–10% neutral lipids –mainly cholesterol–, and 8–10%
proteins, with 5–6% of total surfactant mass being constituted by
speciﬁc surfactant proteins [22]. The phospholipid fraction of sur-
factant is mainly responsible for forming surface active ﬁlms at the
respiratory air–liquid interface [19,23], but it also provides the scaffold
or matrix on which the different surfactant structures are assembled.
In the bulk phase of aqueous environments, phospholipids usually self-
organize in the form of bilayers, which is also the structural form in
which surfactant is assembled and stored by the pneumocytes. At
polar/non-polar interfaces such as the air–liquid interface, phospho-
lipids form oriented monolayers, with the headgroups oriented
towards the aqueous phase and the hydrophobic acyl chains pointing
toward the air. The higher the concentration of phospholipid
molecules at the interface, the fewer the number of water molecules
exposed to air and the lower the surface tension, which also deﬁnes a
lower energy required to enlarge the surface exposed while opening
the alveoli during inspiration [22]. Inmostmammals, half of surfactant
phospholipids by mass is composed of disaturated species, mainly
dipalmitoylphosphatidylcholine (DPPC), a scarce phospholipid species
in other tissues. Evolution has probably selected DPPC as the main
phospholipid species in surfactant because at physiological tempera-
ture, the saturated chains of DPPC can be packed to a very high density
at the air–water interface, providing the large reductions of surface
tensions required to stabilize the lung at the end of expiration [17,27].
The kinked chains of unsaturated phospholipid species –constituting
Fig. 1. Structure of lipid phases and membrane-associated proteins in pulmonary surfactant. The cartoon summarizes current models on the structure and orientation of the three
proteins usually obtained associatedwith pulmonary surfactantmembranes, SP-A, SP-B and SP-C. The representation of the oligomeric structure of SP-A has been inspired by electron
microscopy pictures of the protein [54] and the three-dimensional structure determined for the CRD and neck domains of human SP-A [49] (code 1r13 at Protein Data Bank (PDB)),
represented in the ﬁgure. The cartoon of the structure of SP-C has taken as a reference the conformation of the protein as determined by NMR in organic solvents [93] (PDB code 1spf).
The model for the dimer of SP-B has been drawn from predictive studies of the potential position of helical segments in the protein [195]. Differences in organization and packing of
phospholipids have been illustrated in gel, liquid disordered and liquid-ordered phases in bilayers, and in liquid-expanded and liquid-condensed two-dimensional phases in
interfacial ﬁlms. Potential distribution of cholesterol molecules (yellow) in ordered and disordered phases has been also represented.
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interfacially packed beyond a certain threshold and cannot therefore
sustain low enough tensions [28]. This is also the rationale for DPPC
constituting the main phospholipid component in all the clinical sur-
factant preparations available today, those surfactants being obtained
from natural extracts or prepared with synthetic lipids [14,15]. Some
challenging recent data from the group of Hall show that ﬁlmsmade of
unsaturated phospholipid species can also reach stably very low
surface tensions, if they are compressed at high enough speed [29]. It
has been proposed that very rapid compression takes the ﬁlm into a
highly dense vitreous-like state, also competent to sustain very low
tensions. Interestingly, surfactant from heterothermic mammals
adapted to live at relatively low temperatures contains unusually low
levels of DPPC, which is substituted by certain amounts of palmito-
leoylpalmitoyl phosphatidylcholine (PPPC). Packing and ﬂuidity
properties of membranes containing this unsaturated phospholipid
species could be more favourable for surfactant function at low
temperature than that of DPPC-enriched structures, which are optimal
at around 37 °C [30]. Packing propensity is then a main feature to
deﬁne surface activity and organization of surfactant structures, while
the actual packing of surfactant phospholipids does not only depend
on the acyl chain composition but also on temperature, the presence of
other lipids such as cholesterol and, at the interface, the state of com-
pression, as summarized in the cartoon of Fig. 1. At low temperatures,
phospholipid bilayers are in gel phase (called Lβ), in which the lipid
molecules are highly ordered and showmuch reduced lateral mobility.
If the phospholipid possesses saturated chains –such as DPPC– the gel
phase is very highly packed. At temperatures above a threshold, known
as the gel-to-ﬂuid transition temperature or Tm, the bilayers melt to aliquid–crystalline ﬂuid state (called Lα), in which the lipid molecules
gain considerable mobility and are relatively disordered, meaning that
the acyl chains undergo frequent trans–gauche isomerizations at their
C–C bonds. For this reason, this ﬂuid state is also usually known as a
ﬂuid-disordered phase. The melting temperature of DPPC bilayers is
41 °C, slightly above the physiological temperature in homeothermic
mammals. Therefore, pure DPPC bilayers would not be entirely ﬂuid at
37 °C. Bilayers made of unsaturated phospholipid species have much
lower Tm values. Palmitoyloleoylphoshatidylcholine (POPC), for
instance, the main unsaturated phospholipid in surfactant, has a
melting temperature of −3 °C [31]. The presence in surfactant of a
signiﬁcant proportion of unsaturated phospholipid species reduces the
melting temperature of surfactant membranes to values lower than
that of pure DPPC [32,33], making surfactant membranes ﬂuid at
physiological temperatures, which is important to improve their dy-
namical properties as will later be discussed. The gel and ﬂuid phases
in bilayers have some correspondence with the order and packing
deﬁned by the organization of phospholipids in interfacialmonolayers.
Besides temperature, packing at the interface can be also be deﬁned by
changes in compression, i.e., changes in the surface available for the
lipids to redistribute, as occurs during the breathing cycles or is
modelled in surface balances in vitro. At low compression levels,
phospholipid molecules have low packing density and a considerable
conﬁgurational freedom at the interface, constituting what is called a
liquid-expanded (Le) phase [34,35]. In this interfacial Le phase, the
mobility and order of phospholipids would be qualitatively similar to
that in the bilayer Lα phase.When compressed enough at the interface,
phospholipids can reach a highly packed state, known as a liquid-
condensed (LC) phase. The high order and lowmobility of phospholipid
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phase bilayers [36]. As a matter of fact, lipid monolayers can only be
compressed to a liquid-condensed phase at temperatures below the
corresponding Tm of bilayers of the same composition. Interfacial
compression canproceed even further, to reach extremepacking states
which are in principle not accessible to phospholipids in bilayers, and
produce solid-ordered phases (SO). These solid phases are not
compressible any further, and behave as real two-dimensional solids:
the individualmolecules have essentially no translationalmobility and
theﬁlm breaks if compressed beyond a threshold, leading to collapse of
the ﬁlm [37].
Besides temperature and compression, packing of phospholipids in
bilayers and interfacial ﬁlms is also modulated by the presence of
cholesterol. Cholesterol is an important component of native sur-
factant (5–10% by mass), and recent results indicate that cholesterol is
an important element modulating the structure of surfactant mem-
branes [32,38]. In spite of this, cholesterol is systematically removed
from most clinical surfactant preparations available today [14].
Intercalation of enough cholesterol molecules into phospholipid
bilayers and interfacial monolayers decreases packing and increases
mobility of phospholipids in the ordered phases (gel in bilayers, liquid-
condensed in monolayers), producing phases where the phospholipid
molecules maintain a certain order –a reduced number of trans–
gauche isomerizations– but that are much more ﬂuid than tightly
packed pure phospholipid [39–41]. On the contrary, disordered
phospholipid phases gain order in the presence of cholesterol, because
the intercalation of the planar steroid molecules reduces considerably
the conformational entropy of the acyl chains. Presence of cholesterol,
therefore, deﬁnes an organization of particular phases termed Liquid-
ordered (Lo), ordered but ﬂuid, in both bilayers and interfacial ﬁlms.
Phases or regions with low cholesterol in membranes or ﬁlms remain
intrinsically disordered at high temperatures or low compression
levels, and known as the Liquid-disordered phase (Ld). The cartoon in
Fig. 1 illustrates that packing, order and thickness (per layer) increase
in general terms in the order Lα≈Ld≈LebLobLC≈LβbSo in the different
phases.
2.2. The membrane-associated surfactant proteins
The cartoon in Fig. 1 includes a representation of the three speciﬁc
surfactant proteins, SP-A, SP-B and SP-C, which are obtained from
alveolar lavage associated with pulmonary surfactant membranes and
that are therefore considered as surfactant apolipoproteins [3,42]. A
fourth surfactant protein, SP-D, is not usually associated with mem-
branes [43,44] and will not be discussed in this review.
Proteins SP-A and SP-D are hydrophilic in nature and consist of
large macromolecular assemblies belonging to the family of collectins,
Ca2+-dependent C-type lectins possessing both collagen-like and
carbohydrate-recognition domains (CRD) [45]. The quaternary struc-
ture of SP-A consists of a hexamer of trimers. Each trimer contains a
long triple-helical collagenous stem, interrupted at a given point by a
ﬂexible hinge, a helical bundle connector and a globular head, which
contains the CRD domains [46–48]. Through the globular heads,
whose three-dimensional structure has been determined [49], SP-A is
able to bind multiple ligands, including sugars, Ca2+, and phospholi-
pids in a cooperative manner [48]. These activities allow SP-A to bind
to the surface of multiple pathogens, including bacteria, viruses and
fungi, contributing to their elimination from the airways as a part of
the innate defence response [50]. Recognition of SP-A by speciﬁc
receptors in alveolar macrophages stimulates phagocytosis and other
pathogenicidal events [51–53]. Abundant details on the structure–
function determinants and the speciﬁc activities of SP-A can be found
elsewhere [4,43,45,48,50]. What is relevant to consider for the models
discussed in this review is that SP-A associates with pulmonary
surfactant membranes via the CRD domains [54,55], and that Ca2+-
dependent cooperative membrane binding and protein self-associa-tion enables SP-A to promote membrane–membrane aggregation as
assayed in vitro [56–58] (Fig. 2). Although the globular CRD domains
of SP-A interact rather superﬁcially with phospholipid membranes
[59,60], the protein–lipid interaction has both hydrophobic and polar
contributions [48]. It has been proposed that SP-A recognizes ordered
lipid patterns, and that this is the rationale behind a certain preference
for the protein to interact with ordered membranes such as those in
gel-like or in liquid-ordered phases [61,62], and also with ordered
regions or the boundaries between ordered and disordered phases in
interfacial ﬁlms [57,63]. SP-A could have then evolved to bind to or
contribute to clustering of laterally segregated DPPC-enriched do-
mains thought to exist in pulmonary surfactant membranes and ﬁlms.
SP-B is the most important protein in surfactant for sustaining
respiratory physiology. Inactivation of the expression of the SP-B gene
leads to a lethal respiratory failure at birth, as a result of the impos-
sibility of maintaining the lungs open [64–66]. This protein is strictly
required for the biogenesis of pulmonary surfactant and its packing
into LBs [67,68]. On the other hand, extensive research in vitro has
shown that SP-B is very efﬁcient in transferring surface active phos-
pholipid species from membranes into air–liquid interfaces [69–71].
Unfortunately, a model for the three-dimensional structure and the
molecular mechanism of SP-B is still lacking. Analysis of the sequence
of SP-B reveals that this protein belongs to the family of the saposin-
like proteins, which possess small folds of around 80 amino acids
containing amphipathic alpha-helices and three highly conserved
disulphide bridges in invariant positions [72]. All the saposin-like
proteins have activities related to interacting with and inserting to
different extents into phospholipid membranes [72], but SP-B is the
only member of the family which is permanently membrane-asso-
ciated. This is in part due to the high hydrophobicity of the protein,
which is soluble in organic solvents such as chloroform/methanol
mixtures, making it to co-purify with lipids in the extraction methods
used to obtain the lipid moiety of surfactant. Mature SP-B is produced
in the pneumocytes as a result of the processing of a much larger
precursor, proSP-B, of around 400 residues [73]. The protein is ob-
tained from alveolar spaces in the form of a covalent dimer of two 79-
amino-acid polypeptides. The cartoon in Fig. 1 illustrates that SP-B
probably interacts more or less peripherally with phospholipid
membranes and monolayers, with the main axis of its amphipathic
helical segments orientated in parallel to the plane of the lipid layers
[74–76]. The net positive charge of SP-B likely promotes a certain
selective interaction of SP-B with the anionic phospholipid fraction of
surfactant, and particularly with PG [77], although there is at present
certain controversy as to whether SP-B prefers PG-enriched or PC-
enriched membrane regions [78–80]. What has been clearly demon-
strated is that SP-B distributes preferentially in disordered regions of
membranes [32] and interfacial ﬁlms [81]. Detailed physico-chemical
studies have revealed that SP-B has a strong tendency to perturb
phospholipid packing in membranes and ﬁlms, and as a consequence,
to promote leakage of aqueous content from lipid vesicles [82,83],
exchange of phospholipid molecules between membranes [83–85]
and evenwholemembrane fusion events –meaning completemerging
of lipid membranes and aqueous contents– [82,83,86] (summarized in
Fig. 2). It is thought that membrane perturbation by the amphipathic
helical motifs of SP-B could be an important determinant in catalyzing
the transit of phospholipidmolecules from surfactant membranes into
the interfacial surface active ﬁlm. SP-B could in this sense promote
formation and stabilization of certain non-bilayer intermediates
required for efﬁcient phospholipid dynamics [87]. A recent study has
mapped signiﬁcant structure–activity determinants in the sequence of
SP-B, identifying segments particularly active in promotingmembrane
perturbation and protein-mediated membrane–membrane associa-
tions [83]. A cluster of aromatic residues near theN-terminal end of the
molecule has been also proposed as an important determinant
deﬁning high afﬁnity of SP-B to interact with the interfacial region of
phospholipid bilayers and monolayers [70].
Fig. 2. Membrane-perturbing activities and lateral in-plane distribution of surfactant-associated proteins.
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tightly coupled with the differentiation of mammalian lung tissue
[88,89]. This fact and the lack of signiﬁcant homology between SP-C
and any other known protein lead to the general thinking that SP-C
could be themost speciﬁc protein in terms of the biophysical activities
of pulmonary surfactant. Surprisingly, animals lacking expression of
an operative SP-C can breathe and survive [90], suggesting that the
action of SP-C is not as critical as that of SP-B. However, since the ﬁrst
genetic experiments deactivating the SP-C gene were carried out, it
has become clear that deﬁciencies in SP-C are also associated with
severe respiratory pathologies [7,66,91], usually under a chronically
adverse regime, suggesting that SP-C may also be essential to properly
sustain long-term respiratory dynamics. Mature SP-C is a small very
hydrophobic lipopeptide of 35 amino acids, containing palmitoylated
cysteines, which is co-puriﬁed with SP-B and phospholipids in
chloroformic extractions of pulmonary surfactant [92]. Its three-
dimensional structure has been determined by NMR in chloroform/
methanol solutions [93], consisting in a very regular and rigid α-helix
covering approximately two thirds of the sequence and an unstruc-
tured N-terminal segment containing prolines and the palmitoylated
cysteines. In membranes, the helical segment of SP-C adopts a trans-
membrane orientation [94], perfectly suited to traverse the thickness
of a DPPC bilayer in a ﬂuid state. During the biosynthesis of proSP-C, its
transmembrane segment, which will be later the main part of the
mature protein, orientates with its N-terminal end exposed to thecytosol and the C-terminal side to the lumen of the endoplasmic
reticulum [95]. Assembly of SP-C into pulmonary surfactant mem-
branes is coupled with proteolytic processing of proSP-C precursor, to
liberate N-terminal and C-terminal propeptides. When situated at
an air–liquid interface in vitro, mature SP-C orientates with the C-
terminal end exposed to air [96] (see Fig. 1), but there is no clear idea
as to whether SP-C is actually transferred into the interface at the
alveolar spaces in vivo. Different experiments have shown that SP-C,
as well as SP-B, partitions into disordered regions in both bilayers [32]
and monolayers [81,97]. The summary in Fig. 2 also illustrates that SP-
C has been shown to promote exchange of phospholipids between
membranes [98] and between membranes and interfacial monolayers
[99,100], activities associated with the well-known property of SP-C
to promote rapid formation of interfacial phospholipid-based ﬁlms
[85,99,101,102]. Although the molecular mechanism by which SP-C
promotes interfacial adsorption is not known, it has been proposed
that the N-terminal segment of SP-C has a rather dynamic character
[103,104], with the potential to interact and perturb packing in lipid
structures –membranes [105] or ﬁlms [106]– other than the one
where the hydrophobic α-helix is inserted [3,107,108]. Direct
evidences for this mechanism, however, are still lacking. A recent
study suggests that the palmitoylated N-terminal segment of SP-C
could be well suited to stabilize interdigitated-like phospholipid
structures [109] such as those potentially taking part as intermediates
in bilayer-to-monolayer conversions or in bilayer–bilayer fusion.
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play a role in the association of the protein and SP-C-containing
membranes with very well ordered lipid structures such as those
thought to exist at the highest compressed states of the interfacial ﬁlm
[110]. Palmitoylation maintained peptides designed to mimic the N-
terminal segment of SP-C associated with lipid/peptide monolayers
compressed to high pressures, while non-palmitoylated peptides
were irreversibly lost. Taking into consideration that the main part of
SP-C is squeezed-out from highly compressed interfacial ﬁlms [111], it
is conceivable that the N-terminal segment of the protein is the only
motif that, thanks to acylation, maintains association of surfactant
layers with the most compressed interfacial structures (as illustrated,
for instance, in Fig. 2).
3. Membrane packing and unpacking in lamellar bodies
Pulmonary surfactant complexes are assembled in type II pneu-
mocytes and stored in the form of tightly packed membranes in the
LBs. These organelles belong to the endosomal–lysosomal pathway
and their maturation requires proper trafﬁcking of proteins and lipids
along the regulated exocytic pathway [20]. Extensive studies have
approached the way pulmonary surfactant proteins SP-B and SP-C are
synthetised as large precursors in the endoplasmic reticulum and
processed through different intermediates as they are targeted
through the Golgi, the multivesicular bodies (MVBs) and LBs [73,112–
114]. Although it was originally proposed that at least some amount of
SP-A could be also associated with LBs [115] it is now widely assumed
that SP-A is secreted into the extracellular media by a different
pathway and it probably joins and interacts with surfactant mem-
branes once in the alveolar spaces [116,117]. Maturation of the
precursors of surfactant proteins SP-B and SP-C include several
proteolytic steps, which are apparently coupled with the progressive
acidiﬁcation occurring in the exocytic compartments [20,73,112,118].
MVBs are organelles containing numerous internal unilamellar
vesicles and are supposed to be the organelles preceding the ﬁnal
assembly and storage of surfactant [68,119]. Surfactant proteins and
lipids also reach LBs once taken up again by endocytosis from the
extracellular material and recycled into new surfactant [117,120].
However, no model has been proposed for the molecular mechanisms
behind the biogenesis of themembranes as they are stored into the LBs,
both from the point of view of how the particular lipid composition of
surfactant is sorted and how the highly packed state of stored
surfactant membranes is generated and stabilized. Understanding
packing and organization of surfactant membranes in LBs would also
provide clues about the mechanisms by which surfactant membranes
are unpacked upon secretion and adsorb at the air–liquid interface.
3.1. Role of proteins in the biogenesis and organization of LBs
The study of genetic models in which the expression of surfactant
proteins couldbe inactivatedmade clear veryearly that biogenesis of LBs
is tightly connected with the expression and maturation of surfactant
protein SP-B in type II cells. Lack of SP-B expression seems to be always
accompanied, in both genetic animal models [64,68] and patients
bearing inherited genetic deﬁciencies [6,8,66], of a deﬁcit of LBs and an
accumulation of MVBs in the pneumocytes. This observation conﬁrmed
thatMVBs are probably the precursors of LBs, but also that the presence
of the mature form of SP-B is somehow required for surfactant mem-
branes to accumulate and pack in LBs. In the absence of SP-B, MVBs also
accumulate a partially processed form of SP-C [121], indicating that full
maturation of this protein requires either a direct interaction with SP-B
or the type of membrane transformations that is promoted by SP-B. A
hypothesis that has been proposed suggests that the proteases
responsible for the last proteolytic steps in SP-C maturation might not
have access to the lumen of the internal vesicles of MVBs unless SP-B
exerts its lytic and fusogenic activities [73]. The membrane orientationof SP-C would be in principle preserved from the orientation of the
protein at the endoplasmic reticulumand theGolgimembranes through
the membrane budding process thought to be the source of the
inner vesicles in MVBs. This orientation would then preclude proper
processing of the domain exposed to the lumen of the vesicles –
topologically equivalent to the cytosol– by proteases residing in the
endosomal-like compartments of MVBs. Membrane reorganization
promoted by properly matured SP-B would gain access to the lumen
of the internal vesicles permitting the complete processing also of SP-C.
The hypothesis is appealing, but it still has to be demonstrated. On the
other hand, tight packing of membranes in LBs could include the type of
membrane–membrane interactions that SP-B is able to promote, at least
in vitro [69,82,86,122], but this situation has still to be conﬁrmed. As
stated above, complete SP-B and SP-C processing requires a proper
acidiﬁcation along the exocytic pathway. Acidic pH –thought to be
around 5.5 in LBs– could be also a major driving force to trigger full
membrane packing, once proteins and lipids achieve a proper con-
formation and state of charge [118,123].
In recent years, however, a protein that has gained a major leading
role in the biogenesis of surfactant and LBs is a membrane protein
called the ATP-binding cassette transporter A3 (ABCA3). This protein
belongs to a family of membrane transporters, which use the energy
from ATP hydrolysis to pump differentmolecules across cellular mem-
branes [124,125]. Many of these transporters act in fact as ﬂippases,
proteins catalyzing the transmembrane movement of phospholipids,
which would otherwise translocate at a very slow rate [126–128]. The
ABCA3 protein is probably a lipid translocase selective for saturated
phospholipid species. This would explain why genetic deﬁciencies in
the ABCA3 gene lead to failures in the accumulation of saturated
phosphatidylcholine (PC) species in surfactant, lack of lamellar bodies,
and the development of fatal respiratory distress syndrome in
newborns [129,130]. It has therefore been proposed that ABCA3 is
responsible for pumping surfactant lipids into endosomal-like com-
partments to originate lamellar bodies [131,132], in conjunction with
SP-B and SP-C, which would organize the lipids in the form of tightly
packed membranes. Exogenously expressed ABCA3 leads in culture
cells to the accumulation of PC and cholesterol into lysosomes [133],
supporting this hypothesis. It is important to notice that several of
these ABC-type ﬂippases are responsible for maintaining asymmetry
of most cellularmembranes, through selectively pumping certain lipid
species from one leaﬂet of membranes to the other [134–136]. In this
sense, it is remarkable that no study has been published so far on the
possible asymmetric distribution of lipid species at the two sides of
surfactant membranes. Membrane asymmetry caused or maintained
by ﬂippases has been in fact proposed as a major driving force in the
biogenesis and trafﬁcking of other membrane systems [127,137].
Fig. 3 illustrates the possible mode by which pumping of saturated
lipid species by ABCA3 could promote accumulation of surfactant
membranes inside LBs. A simple but continuous energy-supported
translocation of phospholipids from the outer into the inner leaﬂet of
the compartment would create an imbalance in the number of phos-
pholipid molecules towards the inner side of the membrane.
Selectivity of the pumping activity in favour of saturated species
would also originate an asymmetric character of the membrane. The
progressive accumulation of phospholipids into the inner leaﬂet could
only be relaxed upon creation of membrane folds, which would pro-
trude membrane structures into the lumen of the compartment. The
driving force of asymmetric lipid pumping to promote membrane
budding has been already demonstrated [138]. Vesiculation initiated
and promoted by a continuous pumping of lipids into the inner leaﬂet
of the limiting membrane could be the main mechanism behind the
biogenesis of MVBs. Alternatively, folds originating mainly from the
inner leaﬂet of the limitingmembrane could protrudemembranes into
the lumen, which would be enriched in the lipids selectively pumped
by ABCA3. The activity of the ABCA3 transporter could then explain at
the same time the accumulation of saturated species in surfactant
Fig. 3.Model for the activity and the role of the ATP-binding cassette protein ABCA3 in the biogenesis of lamellar bodies. The ATP-binding cassette ABCA3 uses the free energy of ATP
hydrolysis to catalyze translocation of phospholipids across the limiting membrane of lamellar bodies, with selectivity towards saturated phospholipid species. The model in a)
illustrates howABCA3-promoted continuous pumping of phospholipids could initiate membrane folding from the inner leaﬂet of endosomal/lysosomal compartments. Alternatively,
and as indicated inmodel b), accumulation of saturated phospholipids in the inner leaﬂetmight promote budding and vesiculation to yield accumulation of inner vesicles as observed
in multimesicular bodies (MVBs). SP-C has been included in themembranes just to show how the orientation of the protein could bemaintained through LB biogenesis, following the
insertion of proSP-C in the endoplasmic reticulum. Further accumulation and tight packing of parallel or concentric surfactant membranesmight require the concerted action of SP-B,
as discussed in the text. Concentric (cLB) and parallel (pLB) morphologies of surfactant membranes in LBs may reﬂect differences in the packing state of surfactant. Electron
microscopy pictures of MVB and pLB were a generous gift of Dr. Mattias Ochs, from University of Bern. The electron microscopy picture of cLB was provided by Dr. Paul Dietl, from
University of Ulm in Germany.
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surface– and the driving force to produce and accumulate membranes
in the lumen of MVBs, which in a later stage would be packed to
produce the lamellar bodies. Properly matured SP-Bmight be required
to drive membrane–membrane packing, whichmight be necessary for
maximal accumulation of membranes. In the presence of ABCA3 but in
the absence of SP-B, membranes could only maintain a loosely packed
state such as the one in MVBs. The cartoon in Fig. 3 also illustrates that
presence of ABCA3 in the inner membranes could promote further
membrane vesiculation at different levels, potentially explaining the
“onion-like” morphology of apparently concentric membranes fre-
quently observed in LBs. However, the cartoon clearly illustrates that
most of thesemembraneswould be interconnected topologically –also
with the limitingmembrane–, a condition that could be very important
for a rapid and cooperative unpacking of the whole structure upon
secretion. A wide examination of previously published electron
microscopy pictures of LBs suggests that considering their morphol-
ogy, there are twomain classes of these organelles. A picture of each of
these two types has been included as an example in Fig. 3. Some of
them appear to contain round –spherical 3D– concentric-like mem-
branes, with frequent but clearly discrete contacts between them.
Others accumulate very tightly packed stacks ofmembraneswhich are
parallel to amain axis of the LB, and are apparently in a close contact at
their whole surface. The two types of LBs could represent different
stages of packing, which could depend on the establishment of pos-
sible protein-promotedmembrane–membrane interactions. Participa-
tion of SP-B in promoting such membrane packing could at least
partially explain its major role in LB biogenesis.
The ABCA3 machinery would then be the main factor responsible
for converting the energy provided by ATP hydrolysis into a sphere of
packed membranes, the LB, which could be energetically poised to
rapidly expand and unpack once the limiting membrane is open,
presumably upon secretion. An open question remains as to the po-
tential role of creating and maintaining lipid asymmetry in surfactant
membranes, which could deﬁne, together with probable asymmetric
orientations of surfactant proteins in the membranes, the occurrence
of speciﬁc lipid–protein and protein–protein interactions governing
surfactant morphology at different membrane sides.
3.2. Unpacking LBs
The ﬁnal packed state of LBs could suppose a pre-loaded structure,
energetically primed to favour very rapid and efﬁcient unpacking once
secreted to the extracellular alveolar environment. Recent observation
of type II pneumocytes under dark-ﬁeld microscopy reveals that secre-
tory vesicles, i.e. LBs, show a strong scattering contrast (Paul Dietl,
unpublished observations), consistent with a gradient of dense packing
from the center towards the most external layers. ABCA3-promoted
packing of LBs might progressively increase membrane packing until
internal pressure canno longer beovercomeby the free energy liberated
by ATP hydrolysis. Fusion of the limiting LBmembrane with the plasma
membrane of pneumocytes could almost instantaneously liberate the
internal pressure, producing swelling of themembranes and the abrupt
expulsion of membrane complexes usually observed upon secretion in
electron microscopy pictures (i.e. in [139]) (see Fig. 4).
Fig. 4 summarizes some signiﬁcant images and experiments illus-
trating relevant aspects of LB secretion and unpacking. The ﬁrst
interesting observation comes from an extensive work carried out by
the group of Drs. Paul Dietl and ThomasHaller [18,140–142]. They have
extensively used the ﬂuorescent probe FM-143 as a marker for LB
exocytosis. This ﬂuorophore can be added externally to the extra-
cellular medium of type II cell primary cultures, and only shows
signiﬁcant ﬂuorescence when it inserts into phospholipid membranes
[142]. FM-143 cannot traverse membranes, so it can only insert into
and ﬂuorescently label membranes exposed to the external environ-
ment. Pictures and cartoons in Fig. 4a illustrate how FM-143 induces arapid increase in bright ﬂuorescence, as soon as a given LB fuses with
the plasmamembrane and the fusion pore permits the entrance of the
probe. Secreted LBs can be therefore easily distinguished from non-
secreted organelles under a ﬂuorescent microscope. The interesting
feature is that apparently, all membranes inside the secreting LB
become rapidly intensely labelled. This means that the internal mem-
branes do not isolate different aqueous compartments inside each LB,
but that the entire secreted membrane surface is simultaneously
exposed to the external medium. A model of surfactant membrane
packing such as the one suggested in Fig. 3 would be consistent with
this observation. The work by Dietl et al. has also shown that once the
fusion pore is formed, it still takes some time for the packed mem-
branes to be completely expelled out of the cell [143]. Connection
through the fusion pore of the internal medium of LBs with the extra-
cellular environment probably triggers changes inmembrane packing,
due perhaps in part to re-hydration but also possibly to pH
neutralization and other potential changes in the ionic environment,
including a decrease in Ca2+ concentration, considering that calcium
concentration inside LBs is ﬁvefold higher than in the surrounding
alveolar environment [144]. These changes could induce the partial
unpacking of LB membranes often seen in just fused LBs (i.e. in the
picture in Fig. 4b) (i.e. in [139]). Very often, unpacking of multilamellar
arrays of LBs seems to proceed at deﬁned peripheric points of the
secreted body (as can be seen, for instance, in the picture of Fig. 4c),
with inner layers being expelled out of the LB before themore external
ones. A reason for that could be the increasing pressure gradient
towards the center of the LB that could be implicit to themechanism of
progressive packing by ABCA3 pumping. One cannot discard the pos-
sibility that coupling of membranes through deﬁned protein–protein
interactions creates speciﬁc and localized structures that facilitate a
cooperative unpacking. Microscopic observations also reveal that a
main part of the secreted membranes retains a packed state, where a
signiﬁcant proportion of membrane–membrane contacts are retained
[18,145]. The picture in Fig. 4d illustrates that the mechanism for
membrane unpacking could include the slipping of some membranes
over their neighbour ones, while maintaining their relative separation
[146]. This feature suggests the possible existence of very dynamic,
possibly protein-mediated, membrane–membrane interactions. Lipid–
protein and protein–protein interactions could mediate membrane
packing in the environmental context of the endosomal compartments,
but lead to membrane unpacking under the different circumstances of
the external medium. Optimization of the unravelling of LBs could
require participation of other molecular elements such as additional
proteins joining surfactant membranes once they are in the exterior
hypophase milieu. SP-A secreted to the alveolar spaces from alternative
pathways [146] could contribute to unpacking LBs mainly through
conversion of multilamellar arrays into tubular myelin, as will be
discussed later. It is important to consider, however, that parameters
conditioning LB unpacking could be very different in the alveolar spaces
in vivo,where both the respiratory dynamics and the secretion products
of other cell types can also play a role, than in isolated cultured cells.
Unpacking factors might even be subjected to modulation in real phys-
iological situations.
An interesting observation is that in type II cell primary cultures,
most secreted surfactant remains in the form of lamellar body-like
packed particles for a relatively long time, from minutes to hours
[143,146,147]. Though packed, these particles maintain a state which
is highly competent for interfacial adsorption. Fig. 4e illustrates a
typical experiment from those published by the group of Haller [146],
showing how individual secreted LBs are very efﬁcient in transferring
surfactant material into the air–liquid interface [147]. As a single,
packed, LB approaches and touches the interface it suddenly explodes
and transfers almost instantaneously its material –lipids, protein and
ﬂuorescent markers– into the interface. Transferred material remains
for a relatively long time of a few minutes in a deﬁned region of the
interface, as if there were limitations to free lateral diffusion of lipids –
Fig. 4. Unpacking of secreted lamellar bodies. a) Combined dark-ﬁeld and FM-143 ﬂuorescence images of lamellar bodies as they are secreted by primary cultures of type II
pneumocytes, at different time points after stimulation by secretagogues. The cartoon illustrates how the red dark-ﬁeld image identiﬁes intracellular lamellar bodies, which are not
initially labelled by the yellow ﬂuorescent probe FM-143 because it cannot cross the plasma membrane. Fusion of the limiting membrane of LBs with the plasma membrane, allows
the entrance of the probe into the lumen of the secreting LB and heavy labelling of surfactant membranes. Microscopic images generously provided by Dr. Paul Dietl, from University
of Ulm. b) Electronmicroscopy illustrating how surfactant membranes in LBs may swell and spontaneously unpack as soon as the organelle fuses with the plasmamembrane (picture
provided by Dr. Stephen Young from Pennsylvania University). c) Unpacking of internal surfactant membranes through speciﬁc peripheral locations of a lamellar body (electron
microscopy by courtesy of Dr. Paul Dietl, Univ. of Ulm). d) Sliding of surfactant membranes during unpacking of a lamellar body (reproduced from [146] with permission). e) Sequence
of microscopy pictures illustrating how a single surfactant lamellar body-like particle approaches the interface (t=0), touches it (t=9 s) and almost instantaneously “explodes” and
transfer all the phospholipids into an inverted air–liquid interface. Fluorescently-labelled lipids transferred into the interface look conﬁned in a deﬁned interfacial region for long
periods, indicating that lateral diffusion of lipid species is limited in the plane of the interface. Images reproduced from [146] with permission.
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that the network of lipid–protein interactions maintaining membrane
packing in the secreted LBs could also be responsible for maintaining
the material in a low-diffusible state upon transfer, either at the
interface itself or as part of surface-associated multilayer complexes.
The remarkable efﬁciency of the LB structure to be transferred at once
into the interface could be essential for a rapid surfactant replenish-
ment of the respiratory interface in vivo. The elaborated architecture
of membrane arrangements in LBs could have been evolutionarily
optimized for this purpose, and it is surely very distinct from the
organization and the surface behaviour of the type of lipid/protein
complexes composing the clinical surfactant preparations currently in
use. Inverted phase experiments show that transfer of material from
secreted LBs into the interface is modulated by surface tension [147],
suggesting that most material could maintain a packed state until the
precise moment when the interface needs to be replenished. Thus,
packed lamellar bodies could be less prone to inactivation by binding
serum components than the more exposed membranes of clinical
surfactants [148]. In vivo, secreted but still packed LBs, ready to
transfer material into the interface, could coexist with unpacked
structures fulﬁlling complementary functions such as establishmentof defence networks or organization of dense surface phases opti-
mized for mechanical resistance under the demanding circumstances
of respiratory physiology.
4. Ordered membrane organization in tubular myelin
Electron microscopy pictures of surfactant material puriﬁed from
alveolar lavage or from whole lung tissue, reveal that a signiﬁcant
fraction of secreted surfactant membranes rearrange in a very unusual
ordered network of membranes called tubular myelin (TM) [139,149].
This membrane-based structure has a remarkable architecture,
which is not found in any other animal tissue. Material secreted from
pneumocyte cultures only seldom shows TM ﬁgures (Dr. Paul Dietl,
personal communication), suggesting that TM assembly requires both
secreted surfactant and additional complementary elements, which are
available at sufﬁcient concentration in the alveolar spaces such as,
perhaps, the collectin SP-A. The seminal reconstitution studies carried
out by Suzuki's group [150] early established that TM organization
requires the presence of phospholipids DPPC and PG, proteins SP-A and
SP-B, and Ca2+. Consistent with this observation, animals in which the
expression of SP-A was inactivated lacked TM [151,152]. Interestingly,
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birth, suggesting that TM has no an essential role in the biophysical
function of pulmonary surfactant. As SP-A ismainly implicated in innate
defence [4], current thinking assumes that TM structure plays also some
role in optimizing clearance of pathogens, although no rational
hypothesis has been raised to explain how TM, and the particular
organization that SP-AandSP-B adopt in such a structure, could enhance
defence actions.
Still, the way surfactant proteins re-organize membranes to pro-
duce TM is remarkable, and deserves some discussion. As stated above,
the SP-A macromolecule is a major determinant for TM organization.
Membranes in TM arrange in an ordered pattern, whose dimensions
are relatedwith themolecular size of SP-Amacromolecule. As amatter
of fact, manipulation of the size of SP-A, through genetic modiﬁcation
of the segment of the gene codifying for the collagenic stem, gave rise
to a correlation between the size of the protein and the dimensions of
the membrane pattern in TM [54]. Architecture of TM must therefore
rely on the properties of SP-A to interact with membranes and other
surfactant proteins. Fig. 5 displays some signiﬁcant pictures illustratingFig. 5. Interaction of surfactant protein SP-A with phospholipid membranes. a) Electron mic
membranes at a superﬁcial (left micrography) or a curvedmembrane (right micrography) disp
to practically all of the globular domains could be the difference between the two dispositions
been magniﬁed below, to show how the N-terminal end of SP-A molecule seems to adopt a w
interacting motif. EM pictures have been reproduced from [54] with permission. b) Effect
grooves of regular dimensions. The EM picture (reproduced from [161] with permission) haand interpreting how SP-A interacts with and modulates membrane
structure at amacroscopic scale. Themacromolecular character of SP-A
assembly allows direct observation of the disposition of the protein
when it associates with the surface of membranes [54,55], as illus-
trated in the electron micrographs of Fig. 5a. The typical disposition
of SP-A at the surface of membranes consists of an apparent direct
interaction of most of the globular heads –those containing the Ca2+-
dependent CRD domains–with the membrane, while the collagenous
stem points more or less perpendicularly away from the membrane
plane. This is consistent with experiments that determined that the
phospholipid-binding motif of SP-A is located at the CRD globular
domains [153,154]. The high resolution of the micrographs taken by
Palaniyar et al. allows observation of an interesting feature. As the
detailsmagniﬁed in Fig. 5a illustrate, the endof the collagenous stemof
each SP-Amolecule shows a clearly deﬁned Y-shaped structure, which
could be important to deﬁne speciﬁc interactions of this part of the
protein with other SP-A molecules, receptors, etc. To our knowledge,
no data has been provided so far on the possible three-dimensional
structure of theN-terminal end of the SP-A assembly in spite of the factroscopic pictures illustrating the interaction of hexadecameric SP-A with phospholipid
osition. The cartoons on the right interpret how the interaction of only a fewas opposed
of the protein in themembranes. Details of SP-A structure enclosed inwhite boxes have
ell-deﬁned Y-shaped structure, which could be the basis for a potential protein/protein
of SP-A to promote formation of “corrugated” phospholipid membranes, with deﬁned
s been interpreted according to the cartoon.
1686 J. Pérez-Gil / Biochimica et Biophysica Acta 1778 (2008) 1676–1695that this segment of the molecule has been proposed as a critical
element in lipid–protein and protein–protein interactions, including
SP-A/SP-A network organization or interaction of SP-Awith its cellular
receptors [155,156]. Protein–protein interactions through the N-
terminal end of their collagenous stems is a very important function
for other collectins such as SP-D [60,157], but again no information is
available about the structural context of such interactions. Most
structural work with collectins has been mostly focused so far on the
study of the folding and functional determinants of the globular
domains [49,60,158,159].
In some pictures, such as the one on the right of Fig. 5a, binding of
SP-A creates a deep depression in the membrane, with some localized
markedly curved regions [54,55]. How SP-A could pass from the planar
disposition at the membrane surface to the curved membrane
situation is not known. A possibility is that the membrane depression
would be created upon extensive interaction of the globular domains,
and perhaps also the segments connecting the collagen with the
globular heads, with the membrane, in a particular conformation.
Lateral protein–protein interactions of the different globular heads
from a given SP-Amolecule could also be important to establish a rigid
membrane-interacting protein platform. Another possibility is that
interaction of SP-Awith themembrane could sort the lipids laterally to
segregate a region particularly enriched in saturated species. It has
been demonstrated that SP-A has some preference to interact with
ordered arrays of phospholipid headgroups such as the ones organized
in ordered lipid phases [61,63,160]. SP-A-promoted curved mem-
branes could be a result of creation by SP-A of boundaries between
ordered rigid membrane phases and ﬂuid, more deformable, mem-
brane regions.
Whatever the molecular reason, the potential of SP-A to create
membrane curvature and membrane deformations could be greatly
enhanced in a cooperative manner at enough protein densities, as
shown by several groups [161–163]. Fig. 5b shows a very suggestive
picture in this respect, taken by the group of Dr. Nades Palaniyar. SP-A
favours phospholipid membranes to adopt a corrugated structure, in
which membrane shows distinct hills and valleys, with very regular
dimensions [161]. A somehow corrugated structure was observed also
in protein-free DPPC-containing lipid membranes, suggesting that the
protein could interact and perhaps stabilize periodical lipid arrange-
ments pre-existing in the membranes. Bilayers made of DPPC are
known to form by itself a ripple phase [164] at temperatures between
the pretransition –around 32 °C– and its main thermotropic transi-
tion, at 41 °C. A similar corrugated-like structure adopted by DPPC-
enriched membrane regions could be the structure somehow
stabilized by SP-A. It was demonstrated that the valleys in the
membranes are associated with long-range SP-A alignments. There-
fore, as illustrated in the cartoon in Fig. 5b, the corrugated membrane
structure could also include deformations induced by alignment of SP-
A molecules in the membrane. The alignment of SP-A could be the
entropic consequence of a thermodynamically favourable segregation
of SP-A-promoted deformed membrane regions. A similar mechanism
has been recently proposed as a major force driving long-range
protein-promoted membrane deformations [165,166]. Alternatively,
speciﬁc lateral SP-A/SP-A interactions might mediate the extension of
membrane deformations into the long grooves observed in corrugated
membranes [167]. The ability of SP-A to self-associate in ﬁbers and
ﬁbrous networks [55] could be the basis of the particular arrange-
ments of the protein in the TM structure once the SP-A molecules get
orientated at the surface of the membranes. The conclusion is that the
combination of membrane–protein and protein–protein interactions
of SP-A supplies the potential of SP-A to modulate membrane
structure at a macroscopic scale.
Fig. 6 presents a model suggesting how SP-A interactions could
mediate organization of TM architecture. Pictures in Fig. 6a illustrate
the remarkable regular structure of membranes in TM [145]. Those
transmission electron micrographs typically show that membranesin TM form a square lattice, with the membranes apparently
crossing each other at regular distances. To our knowledge there is
no data about whether intersecting membranes in TM are really
fused, just apposed, or whether the crossing membranes are
locations where lipids adopt non-bilayer structures. The correlation
between the dimensions of the square pattern of TM and the
molecular size of SP-A strongly supports the view that the lattice
could be a consequence of regular deformations induced by SP-A
arrays, such as those observed in corrugated membranes. Some
pictures obtained by Palaniyar et al. revealed a very important
feature [161], as shown in Fig. 6b. Fixation of TM membrane ﬁgures,
followed by delipidization, allowed the observation under TEM of
the presence in TM of an ordered network of protein, in the form of
ﬁlamentous crosses occupying the lipid-free square spaces in TM
tubes. Those protein-made crosses could be interpreted as an
apposition of four SP-A molecules, contacting one to another
through the N-terminal end of the collagenous stem. This disposi-
tion was suggested by Palaniyar et al. [54] and previously by others
[168], but no clear model has been proposed for the way the
membranes could be forced to adopt the TM network. However, in
our opinion, the disposition of SP-A molecules in TM with contacts
through their N-terminal ends immediately suggests a possible
model for a transition from SP-A-promoted corrugated membranes
into the square tubular structure of TM membranes, in a similar way
to what it was already suggested by Palaniyar et al. [167], which is
schematized in Fig. 6c. Two corrugated membranes could couple
their grooves one to another by the direct interaction of the N-
terminal collagenous ends of the SP-A molecules aligned in the
valleys. Similar interactions could make SP-A promote lipid vesicle
aggregation, with the important participation of the N-terminal
segment of the protein [60,156]. Cooperative contacts between SP-A
molecules regularly distributed in the two contiguous membranes
would create a layer of square-shaped tubes. The square shape
would be a consequence of the membrane deformation induced by
SP-A, as observed already in the sharp edges of the grooves in
corrugated membranes [161]. Apposition of two corrugated mem-
branes through SP-A/SP-A interactions would also put in contact the
membranes themselves at the “hills” between the “grooves”. Such
membrane–membrane interactions could be supported or facilitated
by the presence, in these abutting regions, of SP-B, a protein known
to induce membrane–membrane interactions. This process could be
followed by real membrane fusion [69,83,86,122], also required to
assemble TM [150]. Apparently crossing membranes could then be
really fused or perhaps only closely apposed via SP-B/SP-B or SP-B/
membrane interactions. Similar association of not only two, but
multiple SP-A-modelled corrugated membranes would extend TM-
like structure in the third dimension. The model would predict that
only SP-A dimers –formed through interaction of the N-terminal
ends of two SP-A hexadecamers– would be enough to trigger
membrane organization in the TM-like architecture. The protein
crosses observed in TM structure [161] could be a consequence of
either a two-dimensional projection of SP-A dimers orientated in
two different perpendicular dispositions inside each tube or the
interaction via their N-terminal ends of four different SP-A
molecules –two dimers– at each node of the membrane network.
Isolation and structural characterization of native-like SP-A suprao-
ligomers would shed some light on this respect. It is interesting to
notice that there are apparently some differences in the structure of
some of the TM ﬁgures shown in the literature. In some pictures, it
seems that the proteinaceous ﬁlaments –presumably SP-A– are
more or less homogeneously distributed in the TM lattice (for
instance, in Fig. 6b). However, in TM-like structures observed as
directly forming from lamellar body unpacking, it is usually noticed
that square tubules with two types of shapes coexist, which are
alternately arranged (see, for instance, Fig. 6a and the magniﬁed
detail). SP-A-like structures seem to locate, in such “early” TM, only
Fig. 6. Structure and molecular model for the assembly of tubular myelin. a) Electron microscopy picture illustrating howmembranes from LBs can unpack to form the square-lattice
network of membranes typical of tubular myelin. The magniﬁed detail illustrates how the square tubes in TM that has been just assembled from unpacked LBs are of two types, with
well differentiated sizes, with only the smaller ones containing SP-A-like ﬁbrous structures (identiﬁed by arrows). The picture, by courtesy of Dr. Stephen Young, from Pennsylvania
University. b) Protein lattices in delipidized TM samples, showing the regular disposition of proteinaceous cross-like ﬁgures in the square-lattice pattern deﬁned by pre-existing
membranes. Figures represent negative staining and its reverse contrast. Taken from [161] with permission. c) Model for the possible SP-A and SP-B-promoted assembly of TM
network. Pairs of SP-A-corrugated membranes could couple via SP-A/SP-A interactions mediated by their N-terminal domains. Additional membrane layers could be assembled
through protein–protein interactions. Membrane–membrane contacts could be favoured or progress towards realmembrane fusion in the presence of SP-B, which has been shown to
be required to reconstitute TM in vitro.
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could be an intermediate form upon the primary interaction of SP-A
with just one side of the membranes, as they are progressively
unpacked from LBs. Later interaction of further SP-A molecules with
membrane tubes could complete the organization of the very
regular, and probably rigid, structure of mature tubular myelin.5. Interfacial membrane-based surfactant ﬁlms under dynamic
conditions
Membrane unpacking after surfactant secretion ultimately leads to
the adsorption of lipid/protein complexes into the air–water pulmonary
interface [146]. The stabilization by surfactant of the respiratory surface
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mationof an interfacialﬁlm competent to excludemostwatermolecules
from their exposure to air [17]. The potential behaviour of interfacial
surfactant layers has been extensively evaluated in simple surface
balance models, where physiologically relevant conditions such as lipid
and protein composition, compression–expansion rates, temperature,
ionic environment of the subphase, etc, have been extensively studied
[3,17,19,169]. However, it is becoming clear that surfactant ﬁlms as they
are formed in vivo are probably much more complex than the simple
monolayers studied during the last 30 years as fundamental models of
surfactant ﬁlms. Therefore, caremust be takenwhen extrapolatingmost
of the features deﬁned from the studies in basic surface balances to the
real physiological situation.
Basic concepts widely assumed in pulmonary surfactant physical
chemistry include that surfactant ﬁlms must reduce surface tension to
values near 0 mN/m at the end of expiration –in principle, the
maximally compressed state of the respiratory surface– to avoid
alveolar collapse [22]. Also, that just a phospholipid-based monolayer
enriched in saturated species can sustain low enough tension upon
compression, and only at temperatures below the Tm temperature of
the corresponding gel-to-ﬂuid phase transition of the phospholipids
[27,170]. According to these assumptions, DPPC is the major compo-
nent of surfactant in mammals because it is the phospholipid species
optimally selected to form ﬁlms capable of reaching extremely low
tensions when compressed at 37 °C [17,22,23]. The recent data
provided by the group of Hall showing that rapid compression of
ﬁlms made exclusively of unsaturated phospholipids can also produce
very low tensions are challenging the classicalmodel [29]. Unsaturated
phospholipids, as well as other lipid and protein components of
surfactant have been usually considered to play the role of modulating
the properties of DPPC to facilitate its transit to the air–water interface
[19,27,37,171,172]. Some of these other components were also
proposed to promote a progressive enrichment of the interfacial ﬁlm
inDPPC [170,173,174], as thiswas supposedly themain component able
to produce and sustain the lowest tensions. However, these concepts
have arisen mainly from the study of the behaviour under different
conditions of monomolecular ﬁlms formed in surface balances by
spreading lipid or lipid/protein mixtures from organic solvent
solutions. The fact that the two hydrophobic proteins required to
stabilize the lung, SP-B and SP-C, can be puriﬁed and manipulated in
organic solvent has also facilitated their inclusion and study in such
simpliﬁed models. This section will analyze the current basic ideas on
the participation of surfactant proteins and lipid–protein interactions
in interfacial dynamics as it has been mostly proposed from the
models,within the scope of the potential relevance in the physiological
context of the alveolar spaces.
Both, SP-B and SP-C, promote rapid transfer of phospholipids from
membranes into interfacial ﬁlms [71,100,102]. In vitro, adsorption to
open interfaces at relatively diluted surfactant concentrations could
end in an extensive conversion of bilayers into interfacial monolayers
[87,175]. Such conversionmay or may or not imply transfer of proteins
themselves into the interface. At the high surfactant concentrations
thought to exist in the alveolar surface, SP-B and SP-C probably
promote the establishment of molecular connections between the
secreted membrane-based structures and the surface ﬁlm [69]. Those
protein-promoted contacts could ensure a rapid ﬂow of lipids
between the different structures, which is probably important to
facilitate replenishment of the interface with surface active molecules.
Compression of interfacial ﬁlms formed in vitro produces very low
surface tension, both in regular Langmuir-type surface balances
[17,23,171,172] and in captive bubble surfactometers [176], as long as
the ﬁlm contains a sufﬁcient proportion of saturated DPPC. Compres-
sion in Langmuir balances of ﬁlms formed by whole native surfactant
or its organic extract –containing all the lipids plus the hydrophobic
surfactant proteins– show isotherms with very conspicuous plateaus
[37,177], indicative of the existence of structural transitions occurringin the compressed ﬁlms, which are required for the ﬁlms to reach the
lowest tensions. When the ﬁlms are formed and compressed at much
more physiologically relevant conditions in captive bubble surfact-
ometers, i.e. at higher concentrations of surfactant in the hypophase
and relative rapid compression rates, the ﬁlms reach the lowest
tensions with much less compression than in ﬁlms in LB balances
[176,178]. Interfacial ﬁlms formed from native-like concentrated sur-
factant suspensions could therefore be particularly prepared to
sustain very low tensions –high lateral pressures– with very little
change in the surface area. Adsorption of good surfactant preparations
at high enough concentrations in the hypophase has been shown to
produce interfacial ﬁlms comprised of several phospholipid layers,
tightly associated with the interface [179] (see Fig. 7a). Similar inter-
facial multilayer arrays have been observed in electron microscopy
pictures of lung tissue (an example is shown in Fig. 7b), using special
procedures to ﬁx and capture the lipid-enriched interfacial structures
[180]. Other authors have been able to detect and analyze the
repetitivity of membrane structure in surfactant multilayered ﬁlms
made of some partial surfactant preparations [181]. Compression of
these multilayered ﬁlms could yield a different behaviour in terms of
the extent of compression required to reach the minimal tensions
and in terms of stability, than the compression of simple monolayers.
In the in vivo situation, the multilayered ﬁlm would be probably
interconnected with multiple surfactant membrane structures in the
hypophase, including secreted lamellar body-like particles and
tubular myelin arrays, increasing presumably the potential for the
ﬁlm to structurally stabilize the interface under dynamic conditions.
Monolayer experiments with ﬁlms containing different proportions
of surfactant proteins SP-B and SP-C have shown that the two proteins
facilitate ordered and reversible compression-driven structural transi-
tions. Compression of pure lipid ﬁlms usually ends with an irreversible
collapse, in which part of the lipid material is irreversibly lost towards
the hypophase [28,37,161]. The presence of SP-B in ﬁlms under
compression results in the formation of associated bilayer patches (see
AFMpicture and cartoon in Fig. 7c), which can reinsert into the interface
upon expansion [182]. Overcompression of lipid/protein ﬁlms contain-
ing the lipopeptide SP-C also results in formation of multiple associated
layers, presumably bilayers, which were not seen in the absence of the
protein [183,184] (Fig. 7d). Maintenance of the association of the protein
and the lipid/protein structures with the compressed ﬁlms requires the
palmitoylation of SP-C [110], suggesting that palmitoylation could per-
mit this protein to associate simultaneously with and to sustain close
contact between the two neighbour lipid layers. The model sketched in
Fig. 7e suggests that SP-B could be particularly important in ensuring a
rapid, and possibly bidirectional, ﬂow of lipid molecules between the
different surfactant structures and with the multilayer surface-asso-
ciatedﬁlm. Constitutive absence of SP-B compromises the synthesis and
production of surfactant in its primary biogenesis [8,64], but the
respiratory failure associatedwith an induceddepletion of the protein in
conditioned knock-out models [65,83] could rather be associated with
the lack of a proper dynamic ﬂow of lipids interconnecting the whole
alveolar surface. SP-C might have, on the other hand, a major role in
maintaining the integrity of themultilayered surface ﬁlm, providing the
particular properties of stability andmechanical resistance that only the
well packed multilayered structure can sustain. The apparent reduced
stability of the ﬁlms formed by the surfactant of SP-C knock-out mice
[90] would support this hypothesis, aswell as the fact that the lack of an
operative SP-C has been associated with the development over the long
term of chronic respiratory failure [66,91].
In the alveolar spaces, formation of a thick enough surfactant
multilayered ﬁlm at the interface, interconnectedwith enough density
of surfactant structures at the hypophase, could produce a relatively
steady-state situation. The surfactant-loaded surface phase might
then be optimized to sustain breathing dynamics needing very little
change in area/volume of the terminal airways, where gas exchange is
the primary objective. The observation that very signiﬁcant
Fig. 7. Structure of multilayer interfacial surfactant ﬁlms. a) Electron microscopy picture of a segment of the multilayer-like interfacial ﬁlm formed by surfactant at the air–liquid
interface by the lung epithelium (taken from [180] with permission). b) Multilayer-like ﬁlm of natural surfactant adsorbed at the air–liquid interface of a captive bubble (from [179]
with permission). c) AFM picture (from [182] with permission) of interfacial phospholipid ﬁlms containing surfactant protein SP-B. The cartoon illustrates how the progressive
compression of the ﬁlms produce formation of lipid/protein discs of deﬁned sizes, which are maintained in close contact with the interface presumably by lipid/protein interactions
(adapted from [182]). d) Multilayer morphology of a compressed phospholipid ﬁlm containing pulmonary surfactant protein SP-C, as observed by AFM (from [184] with permission).
The cartoon below the AFM picture interprets the structure in terms of membrane layers sustained underneath the interface by simultaneous interaction of SP-C with neighbour
surfactant layers. e) The model shows how in multilayered surfactant ﬁlms, SP-B could be important to initiate protrusion of different membrane layers while palmitoylated SP-C
could help to sustain close association of the different layers along the different compression–expansion respiratory cycles.
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during breathing when comparing a surfactant-containing with a
surfactant-depleted lung [185], would support this view.
6. Lateral structure of pulmonary surfactant membranes and ﬁlms
Much of the research during the last few years on the structure of
pulmonary surfactant layers has been devoted to the analysis of the
lateral in-plane organization of lipids and proteins in membranes and
interfacial ﬁlms. This organization probably explains, on one hand, the
combination of saturated and unsaturated phospholipid species,
charged lipids and cholesterol, which evolved to fulﬁl surfactant
function in the deﬁned context of temperature and mechanical con-
straints of mammalian lungs. On the other hand, an optimized lateral
organization is likely important for pulmonary surfactant to simulta-
neously sustain its dynamic membrane polymorphism and a robust
enough structural role in the airways.The segregation of ordered and disordered regions in pulmonary
surfactant membranes has been recently analyzed using giant
unilamellar vesicle (GUV) technology [32,38] (see Fig. 8). Native
surfactant membranes could be converted into micron-size ﬂuores-
cently-labelled liposomes while maintaining its original lipid and
protein organization. This approach has also been shown to preserve
the original orientation of other membrane-associated proteins [186].
Microscopic observation of pulmonary surfactant GUVs under the
microscope revealed the coexistence of two types of membrane
regions. Part of the membrane surface was occupied by ﬂuid-dis-
ordered domains, surrounded by a background of ﬂuid-ordered phase,
presumably enriched in DPPC and cholesterol. Proteins SP-B and SP-C
partitioned selectively into the ﬂuid-disordered regions. This lateral
segregation of ﬂuid phases was retained even after disorganization of
the original structure by organic solvent extraction or the complete
elimination of proteins, indicating that it is the particular lipid com-
position of surfactant that creates the coexistence pattern. The increase
Fig. 8. Lateral structure of pulmonary surfactant membranes and ﬁlms. a) Segregation of ﬂuid-ordered (red, DiIC18 labelled) and disordered (green, BODIPY-PC labelled) regions in
native pulmonary surfactant membranes, observed in giant unilamellar liposomes (GUVs). Green and red liposomes on the right illustrate that both proteins, SP-B and SP-C, partition
into the ﬂuid-disordered membrane phase, as observed upon introduction into surfactant of traces of Alexa-488-labelled SP-C and Texas-Red-labelled SP-B. b) Heating of native
surfactant membranes to temperatures above 37 °C produces melting of most liquid-ordered phase. c) GUVs prepared from a totally deproteinized lipid fraction of surfactant entirely
mimic the coexistence of ordered/disordered ﬂuid phases of native surfactant membranes, indicating that it is the lipid moiety of surfactant what drives lateral membrane
organization. d) GUVs made of cholesterol-depleted surfactant always show a very polymorphic phase separation, consistent with gel/ﬂuid phase coexistence instead of the ﬂuid/
ﬂuid phase separation observed in native surfactant, illustrating the crucial role of cholesterol in modulating lateral membrane structure. Pictures a–d taken from [32]. e)
Epiﬂuorescence microscopy picture d from Bernardino de la Serna, Bagatolli and Perez-Gil. e) Epiﬂuorescence microscopy image taken from a native pulmonary surfactant ﬁlm
compressed to 37 mN/m, showing segregation of condensed domains excluding a NBD-PC lipid probe. f) AFM image illustrating the nanoscopic structure of a condensed
microdomain segregated from an apparently liquid-expanded background. Notice that bright expanded regions in epiﬂuorescence really contain interconnected condensed
nanodomains when observed under AFM (Antonio Cruz, David Schurch, Luis Vazquez, J. Perez-Gil, unpublished).
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substantial fraction of the liquid-ordered phase, supporting the idea
that a sufﬁcient proportion of saturated lipidswith amelting transition
above physiological temperature is strictly required as a basis for
lateral segregation of phases in surfactant membranes. Removal of
cholesterol also caused a major effect in the lateral membrane
structure, promoting the change from an entirely ﬂuid ordered/
disordered coexistence into a gel/ﬂuid-disordered type of segregation[32,187]. Cholesterol, therefore, seems to be an important determinant
modulating phase behaviour, ﬂuidity and dynamics in surfactant
membranes. To what extent the presence of certain amounts of
cholesterol contributes to optimize the functional performance of
surfactant under the particular environmental conditions of the
alveolar spaces, has still to be fully explored. In several animal models
that have been studied, the level of cholesterol in surfactant seems to
be a factor involved in physiologically-regulated responses to
Fig. 9. Cartoon illustrating how pulmonary surfactant could be responsible for establish-
ing a membrane surface phase at the respiratory surface. The thin aqueous layer covering
alveoli would be saturated of multiple interconnected membrane structures, including
secreted lamellar bodies, tubular myelin and multilayered ﬁlms. The whole surface phase
should be envisaged as a unique structure, simultaneously optimizing respiratory gas
exchange, surface physical stabilization and defence against pathogens.
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high levels of neutral lipids have been found in poorly surface active
surfactant obtained from acute distress syndrome patients [192],
suggesting a deleterious effect of cholesterol on surfactant function.
Mechanisms of adaptation of the surfactant system to challenging
environmental conditions could include concerted changes of the
proportion of cholesterol from or to alveolar reservoirs, as demon-
strated in other air-breathing animals [190]. Determination of the real
existence of such potential cholesterol alveolar reservoirs, as well as
the nature of the molecular sensors supposedly connecting the
alteration of breathing performance with adaptations of surfactant
composition, is a challenging task. The increase in cholesterol could
therefore be a consequence rather than a cause of a poorly-performing
surfactant system. Proteins do not seem to play a major role in
modulating the lateral structure of surfactant membranes, but show a
non-homogeneous distribution based on their lipid phase partition
properties. As said, SP-B and SP-C have been shown to segregate into
theﬂuid-disordered regions of themembranes. The lateral distribution
of SP-A has not been directly visualized, but some indirect evidence
indicates that this proteinwould prefer to interactwith ordered phases
[57,61,63]. The lipid phase “scaffold” of surfactant membranes could
then be a major determinant to initiate or coordinate the three-
dimensional organization of membranes in surfactant structures via
lipid–protein and protein–protein interactions. An important conse-
quence extracted from these studies is that a minimum level of lipid
complexity may be important in surfactant to provide the proper level
of structural complexity. Surfactant preparations containing an excess
of saturated phospholipids, too high electrostatic charge, or exacer-
bated proportions of cholesterol could be far from optimized even in
the presence of substantial levels of proteins, especially under the
environmental conditions of the alveolar spaces.
Segregation of different lipid- and protein-containing regions in
interfacial surfactant ﬁlms has previously been analyzed long ago, as
compression was well known to be a major determinant of lateral
organization. From the earliest experiments applying epiﬂuorescence
microscopy to the observation of interfacial lipid and lipid–protein
ﬁlms, it became clear that the ability of different ﬁlms to reach the
lowest compression-driven surface tensions was related with their
propensity to achieve a highly packed condensed lateral structure
upon compression [34,35,102]. Lateral condensation of simple ﬁlms
composed of DPPC or very simple binary or ternary combinations of
DPPC and other lipid and protein species have been characterized in
detail [34,35,69,71,81,97,102,106]. Lateral transitions in much more
complex ﬁlms, such as those formed by whole pulmonary surfactant
or its organic extract have been studied in much less detail, and
usually in a rather qualitative way. Compression of full complex
surfactant ﬁlms produce segregation of small apparently ﬂuid-
ordered domains [37,177], likely enriched in DPPC and cholesterol,
and presumably excluding hydrophobic surfactant proteins SP-B and
SP-C. This segregation occurs at pressures preceding those where the
plateau originates in the isotherm, which is associated with three-
dimensional folding transitions occurring in the ﬁlms, suggesting that
lateral sorting of lipid and protein components might be an important
feature in deﬁning a proper compression-driven behaviour. Segrega-
tion of ordered/disordered phases in full surfactant ﬁlms is critically
dependent on temperature [187], as occurs in surfactant membranes
[32], but melting temperature of interfacial ﬁlms could be a few
degrees higher than that of bilayers [2]. Lipid composition in
pulmonary surfactant could have therefore been optimized to provide
phase transitions close enough to the physiological temperature, in
such a way that membranes would be mostly ﬂuid and disordered,
and in consequence highly dynamic, while interfacial ﬁlms could still
support enough proportion of ordered phases to sustain the mechan-
ical stability required to maintain proper breathing. In the recent
years, the lateral structure of pulmonary surfactant membranes and
ﬁlms has been also extensively studied by atomic force microscopy(AFM), a technique providing resolution at a nanoscopic level, in the
absence of spurious probes. Observations by AFM have given access to
the analysis of a level of complexity at the nanometer scale in lateral
organization that was not available before, conﬁrming that lipids and
proteins in surfactant are far from being homogeneously distributed
also in membranes [32] and interfacial ﬁlms [193]. The importance of
this nanoscopic organization for the rheological properties and the
functional activities of surfactant is only starting to be appreciated.
However, structural studies of the lateral organization of surfactant
membranes and ﬁlms could still provide only a very simpliﬁed picture
of the real situation. As stated above, surfactant surface structure, as it
is disposed in the thin water layer of the alveolar epithelium, could be
much more complex than a single monolayer in a surface balance or a
single bilayer in a giant liposome. The characterization of the actual
lateral organization of lipids and proteins in the multilayer-like
polymorphic three-dimensional structure of surfactant as it is
interconnecting the whole subphase with the gas phase supposes a
technical challenge that will have to be approached, possibly through
new still-to-come methodological developments, before understand-
ing the ultimate structure–function correlations of the system.
7. An integrated model of pulmonary surfactant structure at the
alveolar spaces
Fig. 9 illustrates an integrated view of how pulmonary surfactant
could develop a sort of membrane surface phase covering the
respiratory surface. The term “surface phase” was ﬁrst suggested by
the group of Larsson [181,194], to point out that pulmonary surfactant
should not be seen as a purely interfacial ﬁlm at the air–liquid
interface but as a complete structure developed in the aqueous lining
layer as a whole. From our point of view, this is certainly an appro-
priate way to interpret surfactant membrane-based polymorphism at
the alveolar airspaces, but in a much more complex view than dis-
cussed by Larsson et al. Part of pulmonary surfactant properties could
come from a sophisticated pre-loaded structure, as assembled in the
pneumocyte, with the potential to develop a complex polymorphism
once secreted into the extracellular medium. But besides that, sur-
factant structures could be poised to integrate lipid–protein entities
liberated into the airways from different origins and modulated by
different environmental and physiological determinants. Just this
complex biological “phase”, developed as a three-dimensional ﬁlm at
the respiratory surface, could be competent to sustain simultaneously
proper respiratory gas exchange, mechanical stabilization under the
dynamic conditions imposed by breathing, and protection against
pathogenic invaders. The disruption of such a complex structure that
is likely associated with lung injury could have many more conse-
quences than a mere impairment of the ability of surfactant to pro-
duce very low surface tensions. A global comprehension of structure–
function determinants in pulmonary surfactant three-dimensional
1692 J. Pérez-Gil / Biochimica et Biophysica Acta 1778 (2008) 1676–1695ﬁlms is still required before therapeutic use of clinical surfactants
might have reasonable chances of success in the treatment of complex
pathologies associated with lung injury.
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